Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis.
Montes-Moreno S, Batlle A, de Villambrosía SG, Sánchez-Espiridión B, Cereceda L, González-Barca E, Purroy N, Pardal E, Martín A, Grande C, Mazorra F, Insunza A, Quero C, Aguiar D, Cruz MA, Rueda A, Llanos M, Codina JG, Arroyo FR, Caballero D, Conde E, López A, Provencio M, Piris M. Montes-Moreno S, et al. Among authors: rueda a. Haematologica. 2014 Aug;99(8):e138-41. doi: 10.3324/haematol.2014.104976. Epub 2014 Apr 24. Haematologica. 2014. PMID: 24763400 Free PMC article. Clinical Trial. No abstract available.
High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma.
Rueda A, Rifá J, Quero C, Gómez-Codina J, Murias A, García-Arroyo FR, Sabín P, Llanos M, Herrero J, Lobo F, Delgado JR, Provencio M; Spanish Lymphoma Oncology Group. Rueda A, et al. Leuk Lymphoma. 2014 Jun;55(6):1413-6. doi: 10.3109/10428194.2013.836601. Epub 2013 Oct 9. Leuk Lymphoma. 2014. PMID: 23964649 No abstract available.
Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry.
Provencio M, Sabín P, Gomez-Codina J, Torrente M, Calvo V, Llanos M, Gumá J, Quero C, Blasco A, Cruz MA, Aguiar D, García-Arroyo F, Lavernia J, Martinez N, Morales M, Saez-Cusi A, Rodriguez D, de la Cruz L, Sanchez JJ, Rueda A; GOTEL (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: rueda a. PLoS One. 2017 May 11;12(5):e0177204. doi: 10.1371/journal.pone.0177204. eCollection 2017. PLoS One. 2017. PMID: 28493986 Free PMC article.
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J, Méndez M, Gómez S, García JF, Martín P, Bellas C, Pedrosa L, Rodríguez-Pinilla SM, Camacho FI, Quero C, Pérez-Callejo D, Rueda A, Llanos M, Gómez-Codina J, Piris MA, Montes-Moreno S, Bárcena C, Rodríguez-Abreu D, Menárguez J, de la Cruz-Merino L, Monsalvo S, Parejo C, Royuela A, Kwee I, Cascione L, Arribas A, Bertoni F, Mollejo M, Provencio M, Sánchez-Beato M. González-Rincón J, et al. Among authors: rueda a. PLoS One. 2019 Feb 25;14(2):e0212813. doi: 10.1371/journal.pone.0212813. eCollection 2019. PLoS One. 2019. PMID: 30802265 Free PMC article. Clinical Trial.
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma.
Pedrosa L, Fernández-Miranda I, Pérez-Callejo D, Quero C, Rodríguez M, Martín-Acosta P, Gómez S, González-Rincón J, Santos A, Tarin C, García JF, García-Arroyo FR, Rueda A, Camacho FI, García-Cosío M, Heredero A, Llanos M, Mollejo M, Piris-Villaespesa M, Gómez-Codina J, Yanguas-Casás N, Sánchez A, Piris MA, Provencio M, Sánchez-Beato M. Pedrosa L, et al. Among authors: rueda a. Sci Rep. 2021 Jan 21;11(1):1886. doi: 10.1038/s41598-020-80376-0. Sci Rep. 2021. PMID: 33479306 Free PMC article.
Survival in young adults diagnosed with follicular lymphoma.
Calvo V, Provencio M, Gómez Codina J, Rodríguez Abreu D, Rueda A. Calvo V, et al. Among authors: rueda a. Ann Oncol. 2016 Apr;27(4):751. doi: 10.1093/annonc/mdv627. Epub 2015 Dec 28. Ann Oncol. 2016. PMID: 26715622 Free article. No abstract available.
Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group.
Rueda A, Calvo V, Casanova M, Rodriguez-Abreu D, Aguiar D, Llanos M, Alvarez R, Martinez-Banaclocha N, Alfaro J, Quero C, Blasco A, de la Cruz Merino L, Herrero J, García-Arroyo FR, Provencio M. Rueda A, et al. Leuk Lymphoma. 2019 Jun;60(6):1576-1579. doi: 10.1080/10428194.2018.1542147. Epub 2018 Dec 5. Leuk Lymphoma. 2019. PMID: 30516082 Clinical Trial. No abstract available.
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Provencio M, Cruz Mora MÁ, Gómez-Codina J, Quero Blanco C, Llanos M, García-Arroyo FR, de la Cruz L, Gumá Padró J, Delgado Pérez JR, Sánchez A, Alvarez Cabellos R, Rueda A; Gotel (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: rueda a. Leuk Lymphoma. 2014 Jan;55(1):51-5. doi: 10.3109/10428194.2013.790544. Epub 2013 Jun 12. Leuk Lymphoma. 2014. PMID: 23573825 Clinical Trial.
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
Provencio M, Sabín P, Gómez Codina J, Rueda A, Llanos M, Gumá J, Quero Blanco C, Blasco A, Delgado JR, Cruz MÁ, Aguiar D, García-Arroyo FR, Herrero J, Lavernia J, Martínez Banaclocha N, Morales M, Fuster J, Sáez Cusi Á, Lobo F, Rodríguez Abreu D, de la Cruz L, Antón E, Rodríguez Jiménez A, Arízcun A, Pérez X; GOTEL (Spanish Lymphoma Oncology Group). Provencio M, et al. Among authors: rueda a. Clin Transl Oncol. 2012 May;14(5):386-90. doi: 10.1007/s12094-012-0813-3. Clin Transl Oncol. 2012. PMID: 22551546
338 results